¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"test for recruitment phenomenon"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • cold pressure test
    ÇÑ·©¾Ð¹Ú°Ë»ç
  • complement fixation inhibition test
    º¸Ã¼°áÇÕ¾ïÁ¦°Ë»ç
  • complement fixation test
    º¸Ã¼°áÇÕ°Ë»ç
  • contraction stress test
    ¼öÃàÀڱذ˻ç
  • Coombs¡¯ test
    ÄñÁî°Ë»ç
  • coordination test
    ¼Õ¹ßÇùÁ¶±â´É°Ë»ç
  • cover-uncover test
    °¡¸²¾È°¡¸²°Ë»ç
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²°Ë»ç
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
  • challenge test
    À¯¹ß°Ë»ç
  • caloric test
    ¿Â¼ö´«¶³¸²°Ë»ç
  • chemiluminescence test
    È­Çй߱¤°Ë»ç
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • D-xylose test
    D-ÀÚÀϷοÀ½º°Ë»ç
  • dye exclusion test
    »ö¼Ò¹èÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • breath holding test
    È£ÈíÁßÁö½ÃÇè, È£ÈíÁßÁö°Ë»ç
  • bulbocavernous evoked-response test
    ¸Á¿ïÇØ¸éü±ÙÀ¯µµ¹ÝÀÀ°Ë»ç
  • bulbocavernous reflex latency test
    ¸Á¿ïÇØ¸éü±Ù¹Ý»ç½Ã°£ÃøÁ¤°Ë»ç
  • caloric test
    ¿Âµµ´«¶³¸²°Ë»ç
  • carbohydrate tolerance test
    ź¼öÈ­¹°³»¼º½ÃÇè
  • carbon monoxide hemoglobin test
    ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó°Ë»ç
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
  • cell-mediated lympholysis test
    ¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
  • challenge test
    À¯¹ß°Ë»ç
  • chelation test
    ų·¹ÀÌÆ®È­°Ë»ç
  • chemiluminescence test
    È­Çй߱¤°Ë»ç
  • chemstrip test
    È­Çжì°Ë»ç
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • children apperception test
    ¾Æµ¿Åë°¢°Ë»ç
  • clearance test
    û¼ÒÀ²½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Coombs consumption test
    Äñ½º¼Ò¸ð°Ë»ç
  • Cosyntropin stimulation test
    ÄÚ½ÅÆ®·ÎÇÉ ÀڱؽÃÇè
  • Cuboni s test
    Äíº¸´Ï½ÃÇè.
  • Cytronbergs test
    ½ÃÆ®·Ðº£¸£Å©½ÃÇè.
  • DAT =>direct antiglobulin test
    Á÷Á¢ Çױ۷κҸ°½ÃÇè
  • DDST=Denver developmental screening test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç
  • DNase test
    DNA ºÐÇØÈ¿¼Ò½ÃÇè
  • DST=dexamethasone supression test
    µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦°Ë»ç
  • Dehydration test
    Å»¼ö°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç(Û¡Ó¹ðàÞÛËþÞÛ)
  • Denver developmental screening test
    µ§¹ö¹ßÀ°¼±º°¹ý.
  • Dick test
    µñÅ©½ÃÇè
  • Dick test
    µñ °Ë»ç
  • Donath-Landsteiner test
    µµ³ª¾²¶õÆ®½ºÅ¸ÀÌ³Ê °Ë»ç
  • Draw-A-Person test(DAP)
    Àι°È­°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • rejection phenomenon
    °ÅÀýÇö»ó(ËÞï¾úÞßÚ).
  • release phenomenon
    À¯¸®Çö»ó.
  • reversed crossing phenomenon
    ¿ª±³Â÷Çö»ó(æ½Îßó¬úÞßÚ) ¸Á¸·ÀÇ .
  • satellite phenomenon
    À§¼ºÇö»ó(êÛàøúÞßÚ).
  • satellite phenomenon
    À§¼ºÇö»ó(êÛàøúÞßÚ)
  • second wind phenomenon
    ÀÌÂ÷ °­È­Çö»ó
  • setting sun phenomenon
    Áö´ÂÇØÇö»ó
  • sickling phenomenon
    °â»óÈ­Çö»ó.
  • sickling phenomenon
    °â»óÈ­Çö»ó(ÌÇßÒûùúÞßÚ)
  • slice entry phenomenon
    ÀýÆí ÀÔ±¸ Çö»ó
  • staircase phenomenon
    °è´ÜÇö»ó(Í­Ó«úÞßÚ)
  • steroid rebound phenomenon
    ½ºÅ×·ÎÀÌµå ¹ÝµµÇö»ó(¡­ÚãÔ¯úÞßÚ).
  • sunset phenomenon
    ÀϸôÇö»ó
  • switch phenomenon
    ½ºÀ§Ä¡Çö»ó(~úÞßÚ).
  • tibial phenomenon =Strumpell s sign
    °æ°ñ Çö»ó(ÌëÍéúÞßÚ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
MIT Massachusetts Institute of Technology; male impotence test; marrow iron turnover; melodic intonation...
PCT peripheral carcinoid tumor; plasma clotting time; plasmacrit test; plasmacytoma; polychlorinated tri...
SCAT sheep cell agglutination test; sickle cell anemia test; Sports Competition Anxiety Test
SCT secretin; sex chromatin test; sexual compatibility test; sickle-cell trait; sperm cytotoxicity; spin...
SIT serum inhibiting titer; Slosson Intelligence Test; sperm immobilization test; suggested immobilizati...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CWT Color Word Test
CF Complement Fixation Test
CFT Complement Fixation Test
C-T Conditioning-Test
CPT Continuous Performance Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone conduction test
    °ñÀüµµ ½ÃÇè
  • Bonsignore test
    º»½Ã±×³ë ½ÃÇè
  • bracelet test
    ¿Ï·û ½ÃÇè
  • breakdown test
    ÆÄ±« ½ÃÇè
  • breath holding test
    È£Èí ÁßÁö ½ÃÇè
  • Brucellosis test
    ºê·ç¼¿¶óÁõ ½ÃÇè
  • butyric acid test
    ³«»ê ½ÃÇè
  • Callaways test
    Ķ·¯¿þÀÌ ½ÃÇè
    »ó¿Ï°ñ Å»±¸ÀÇ ½ÃÇè¹ýÀ¸·Î, °ßºÀ¿¡¼­ °Üµå¶ûÀ̸¦ °ÅÃÄ ÃøÁ¤ÇÑ ¾î±ú µÑ·¹´Â Å»±¸µÈ ÂÊÀÌ ´õ Å©´Ù
  • candida test
    ĵµð´Ù ½ÇÇè
  • Cantanis test
    ĭŸ´Ï ½ÃÇè
  • capillary fragility test
    ¸ð¼¼°ü Ãë¾à¼º ½ÃÇè, ¸ð¼¼Ç÷°ü Ãë¾à¼º ½ÃÇè
    Á¤¸Æ Ç÷·ù¸¸À» ÃæºÐÈ÷ Â÷´ÜÇÒ ¼ö ÀÖµµ·Ï Ç÷¾Ð´ë¸¦ 5ºÐ°£ °­ÇÏ°Ô Á¹¶ó¸Ç ÈÄ¿¡ ÀÌ·Î ÀÎÇÏ¿© »ý±ä ÇǺÎÀÇ Á¡ÃâÇ÷ÀÇ ¼ö¸¦ ¼¼¾î ¸ð¼¼°üÀÇ Ãë¾à¼ºÀ» °Ë»çÇÏ´Â °Í.
  • capillary resistance test
    ¸ð¼¼Ç÷°ü ÀúÇ×¼º ½ÃÇè
  • Cappagnolis test
    İÆÄ³î¸® ½ÃÇè
  • carbohydrate fermentation test
    ź¼öÈ­¹° ¹ßÈ¿ ½ÃÇè
  • carbohydrate utilization test
    ź¼öÈ­¹° ÀÌ¿ë ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
staircase phenomenon A phenomenon in cardiac muscle first observed by H.P. Bowditch; if a number of stimuli of the same intensity are sent into the muscle after a quiescent period, the first few contractions of the series show a successive increase in amplitude (strength).
Synonym: staircase phenomenon.
Origin: Ger. Treppe, staircase
(05 Mar 2000)
Staub-Traugott phenomenon The increased rate of removal of loads of glucose given shortly after administration of an initial glucose load.
(05 Mar 2000)
Negro's phenomenon A sudden brief halt in usually smooth respiration or other motor activity.
Synonym: Negro's phenomenon.
(05 Mar 2000)
Strassman's phenomenon In the third stage of labour, failure of placental detachment indicated by transmission of pressure from the fundus uteri to the umbilical vein which becomes engorged; obsolete term.
(05 Mar 2000)
Strumpell's phenomenon Dorsal flexion of the great toe, sometimes of the entire foot, in a paralysed limb when the extremity is drawn up against the body, flexing both knee and hip.
Synonym: tibial phenomenon.
(05 Mar 2000)
no reflow phenomenon Absence of blood flow in a portion of the brain which has been damaged, usually by ischemia.
(05 Mar 2000)
Danysz phenomenon Reduction of the neutralizing effect of an antitoxin when toxin is mixed with it in divided portions, rather than adding the same total quantity of toxin in one step.
(05 Mar 2000)
dawn phenomenon Abrupt increases in fasting levels of plasma glucose concentrations between 5 and 9 a.m., in the absence of antecedent hypoglycaemia; occurs in diabetic patients receiving insulin therapy.
(05 Mar 2000)
Debre phenomenon In measles, the failure of the rash to develop at the site of immune serum injection.
(05 Mar 2000)
declamping phenomenon Shock or hypotension following abrupt release of clamps from a large portion of the vascular bed, as from the aorta; apparently caused by transient pooling of blood in a previously ischemic area.
Synonym: declamping shock.
(05 Mar 2000)
deja vu phenomenon The mental impression that a new experience (e.g., a scene, sight, sound, or action) has happened before; a common phenomenon in normal persons that may occur more frequently or continuously in certain emotional or organic disorders. Also variously referred to as deja entendu, deja eprouve, deja fait, deja pense, deja raconte, deja vecu, or deja voulu, depending on the experience or sense that is evoked.
(05 Mar 2000)
Dejerine-Lichtheim phenomenon <clinical sign> In subcortical aphasia, the patient can indicate by use of the fingers the number of syllables of a word he has in mind but cannot speak.
Synonym: Dejerine-Lichtheim phenomenon.
(05 Mar 2000)
Dejerine's hand phenomenon Clonic contractions of the flexors of the hand (wrist) on tapping the dorsum of the hand or the volar side of the forearm near the wrist; occurs in normal persons but is exaggerated in pyramidal tract lesions.
Synonym: Dejerine's reflex.
(05 Mar 2000)
symbiotic fermentation phenomenon "two organisms, neither of which alone produces gas fermentation in certain carbohydrates, may do so when living in symbiosis or when artificially mixed" (Castellani).
(05 Mar 2000)
Denys-Leclef phenomenon Enhanced phagocytosis by leukocytes of microorganisms in the presence of immune serum.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á